Global Blood Group Typing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Blood Group Typing Market is presumed to reach the market size of nearly USD 7.01 Billion by 2032 from USD 2.89 Billion in 2023 with a CAGR of 10.33% under the study period 2024-2051.

Blood group typing is a method of determining an individual's blood type. It is done so that one can safely receive and donate blood or transfuse. It is also done to check if one has a substance called Rh factor on your red blood cells surface. It is performed by adding a blood sample to a solution containing antibodies corresponding to each antigen. It is a fast and easy process and allows receiving or transferring the right kind of blood during surgery or after an injury.

MARKET DYNAMICS

Rising blood donations practices through education & blood donation campaigns and increasing incidence when patients require blood supply due to accidents are vital factors that influence the global blood group typing market's growth. Other factors contributing to the growth of the blood group typing market are the growing need for blood for pregnant women and rising forensic research. Blood group typing is essential to perform to check compatibility with the donor blood type, triggering a dangerous immune response. Meanwhile, the lack of skilled professionals and inadequate awareness can lead to misleading transfusion, resulting in a decline in the blood group typing market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Blood Group Typing. The growth and trends of Blood Group Typing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Blood Group Typing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Consumables
Instruments
Services

By Technique

PCR-based and Microarray Techniques
Assay-based Techniques
Massively Parallel Sequencing Techniques
Other Techniques

By Test Type

Antibody Screening
HLA Typing
Cross-matching Tests
ABO Blood Tests
Antigen Typing

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Blood Group Typing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood Group Typing market include Grifols, S.A., Merck KGaA, Bio-Rad Laboratories Inc., Immucor Inc., Novacyt Group, Danaher Corporation, Agena Bioscience Inc., Ortho Clinical Diagnostics, Quotient Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11213668

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BLOOD GROUP TYPING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technique
- 3.7.3 Market Attractiveness Analysis By Test Type
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Consumables Historic and Forecast Sales By Regions
5.5. Instruments Historic and Forecast Sales By Regions
5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY TECHNIQUE

6.1. Overview By Technique
6.2. Historical and Forecast Data
6.3. Analysis By Technique
6.4. PCR-based and Microarray Techniques Historic and Forecast Sales By Regions
6.5. Assay-based Techniques Historic and Forecast Sales By Regions
6.6. Massively Parallel Sequencing Techniques Historic and Forecast Sales By Regions
6.7. Other Techniques Historic and Forecast Sales By Regions

7. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY TEST TYPE

7.1. Overview By Test Type
7.2. Historical and Forecast Data
7.3. Analysis By Test Type
7.4. Antibody Screening Historic and Forecast Sales By Regions
7.5. HLA Typing Historic and Forecast Sales By Regions
7.6. Cross-matching Tests Historic and Forecast Sales By Regions
7.7. ABO Blood Tests Historic and Forecast Sales By Regions
7.8. Antigen Typing Historic and Forecast Sales By Regions

8. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BLOOD GROUP TYPING COMPANIES

9.1. Blood Group Typing Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BLOOD GROUP TYPING INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Grifols
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. S.A.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Merck KGaA
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Bio-Rad Laboratories Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Immucor Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Novacyt Group
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Danaher Corporation
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Agena Bioscience Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Ortho Clinical Diagnostics
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Quotient Ltd
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies